China Healthcare Weekly (Oct.9)
This insight summarized the important industry viewpoints, news of listed healthcare companies and capital market review for the last week of China...
234 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
445 Views
HSCI Index Rebalance - Stock Connect Flows Coming Up
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....
479 Views
Hang Seng Index Rebalance - Big Turnover, Big Impact, Some Surprises and More Changes to Come
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes post market close on 14 August....
977 Views
Innovent Biologics (信达生物) Placement - Back on the Market but This Time with Secondary Selldown
Innovent Biologics Inc (1801 HK) is looking to raise about U$290m to fund expansion and concurrently, shareholders are looking to sell about 33.8m...
477 Views